TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
COYA

Coya Therapeutics, Inc.

Healthcare · Biotechnology

5.00$ -4.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement COYA
Line item 2020 2021 2022 2023 2024 2025
– – – 100.0% 100.0% 100.0%
– – – 91.7% 333.9% 0.3%
– – – 8.3% -233.9% 99.7%
– – – 100.7% 334.6% 210.6%
– – – 130.5% 250.0% 144.1%
– – – 140.0% 251.5% 354.7%
– – – -131.7% -485.4% -255.0%
– – – -121.0% -439.0% -267.1%
– – – 12.1% -20.3% 0.0%
– – – -133.1% -418.7% -267.1%
– – – -122.2% -483.9% -266.8%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?